Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

4.62
Delayed Data
As of Apr 29
 -0.22 / -4.55%
Today’s Change
4.30
Today|||52-Week Range
22.74
-61.08%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close4.84
Today’s open4.85
Day’s range4.50 - 4.93
Volume93,690
Average volume (3 months)129,686
Market cap$99.9M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-3.00%
Earnings growth (this year)-11.49%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1,310.90
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.02-0.88%
GTXIGTX Inc-0.00-0.01%
ASMBAssembly Biosciences...+0.11+1.87%
XENEXenon Pharmaceutical...+0.06+0.85%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$184.0K
Annual profit (last year)-$62.8M
Net profit margin-34,151.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Chief Financial Officer
John B. Green
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs